Epithelial mesenchymal transition in early invasive breast cancer: An immunohistochemical and reverse phase protein array study

Breast Cancer Research and Treatment

Volumn 145, Issue 2, 2014, Pages 339-348

  Aleskandarany, Mohammed A ^a,b   Negm, Ola H ^a,c   Green, Andrew R ^a   Ahmed, Mohamed A H ^a,d   Nolan, Christopher C ^a   Tighe, Patrick J ^a   Ellis, Ian O ^a   Rakha, Emad A ^a,b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b MENOUFIA UNIVERSITY   (Egypt)

^c MANSOURA UNIVERSITY   (Egypt)

^d Suez Canal University Faculty of Medicine   (Egypt)

Author keywords

Cadherin switch; EMT; Immunohistochemistry; Reverse Phase Protein Array; RPPA

Indexed keywords

CADHERIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FORMALDEHYDE; NERVE CELL ADHESION MOLECULE; PARAFFIN; PROTEIN KINASE B; PROTEIN PIK3CA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MARKER; UNCLASSIFIED DRUG; UVOMORULIN; CDH2 PROTEIN, HUMAN; ERBB2 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PIK3CA PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; COHORT ANALYSIS; EARLY CANCER; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MOLECULAR BIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEIN POLYMORPHISM; PROTEIN PROTEIN INTERACTION; PROTEOMICS; QUANTITATIVE ANALYSIS; REVERSE PHASE PROTEIN ARRAY; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; TUMOR INVASION; TUMOR VOLUME; BREAST TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROCEDURES; TUMOR RECURRENCE;

AGED; ANTIGENS, CD; BREAST NEOPLASMS; CADHERINS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN ARRAY ANALYSIS; RECEPTOR, ERBB-2; TUMOR MARKERS, BIOLOGICAL;

EID: 84901680245     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-014-2927-5     Document Type: Article

References (41)

1. Thiery JP, Sleeman JP (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7(2):131-142 (Pubitemid 43278296)
2. Moustakas A, Heldin CH (2007) Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 98(10):1512-1520 (Pubitemid 47308444)
3. Thiery JP (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2(6):442-454
4. Iwatsuki M et al (2010) Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci 101(2):293-299
5. Cardiff R (2010) The pathology of EMT in mouse mammary tumorigenesis. J Mammary Gland Biol Neoplasia 15(2):225-233
6. Tomaskovic-Crook E, Thompson EW, Thiery JP (2009) Epithelial to mesenchymal transition and breast cancer. Breast Cancer Res 11(6):213
7. Polyak K, Weinberg RA (2009) Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nat Rev Cancer 9(4):265-273
8. Wu Y, Zhou BP (2008) New insights of epithelial-mesenchymal transition in cancer metastasis. Acta Biochim Biophys Sin (Shanghai) 40(7):643-650 (Pubitemid 352009085)
9. Xue C et al (2003) The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Res 63(12):3386-3394 (Pubitemid 36735899)
10. Giampieri S et al (2009) Localized and reversible TGF[beta] signalling switches breast cancer cells from cohesive to single cell motility. Nat Cell Biol 11(11):1287-1296
11. Tarin D (2005) The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 65(14):5996-6001 (Pubitemid 40994379)
12. Wicki A et al (2006) Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell 9(4):261-272
13. Tse JC, Kalluri R (2007) Mechanisms of metastasis: epithelial-to- mesenchymal transition and contribution of tumor microenvironment. J Cell Biochem 101(4):816-829 (Pubitemid 47040864)
14. Wendt MK, Smith JA, Schiemann WP (2010) Transforming growth factor-beta-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression. Oncogene 29(49):6485-6498
15. Yang J et al (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117(7):927-939 (Pubitemid 38798858)
16. Lamouille S, Derynck R (2011) Emergence of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin axis in transforming growth factor-beta-induced epithelial-mesenchymal transition. Cells Tissues Organs 193(1-2):8-22
17. Albasri A et al (2009) C-terminal Tensin-like (CTEN) is an oncogene which alters cell motility possibly through repression of E-cadherin in colorectal cancer. J Pathol 218(1):57-65
18. Peinado H, Portillo F, Cano A (2004) Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol 48(5-6):365-375 (Pubitemid 39360388)
19. Hazan RB et al (2004) Cadherin switch in tumor progression. Ann N Y Acad Sci 1014:155-163 (Pubitemid 38594801)
20. Ahmed N, Thompson EW, Quinn MA (2007) Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: An exception to the norm. J Cell Physiol 213(3):581-588 (Pubitemid 350058249)
21. Josson S et al (2010) Tumor-stromal interactions influence radiation sensitivity in epithelial-versus mesenchymal-like prostate cancer cells. J Oncol. doi: 10.1155/2010/232831
22. Lin K et al (2010) The role of B-RAF mutations in melanoma and the induction of EMT via dysregulation of the NF-kappaB/Snail/RKIP/PTEN circuit. Genes Cancer 1(5):409-420
23. Sarrio D et al (2008) Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 68(4):989-997 (Pubitemid 351272216)
24. Spurrier B, Ramalingam S, Nishizuka S (2008) Reverse-phase protein lysate microarrays for cell signaling analysis. Nat Protoc 3(11):1796-1808
25. Speer R et al (2007) Development of reverse phase protein microarrays for clinical applications and patient-tailored therapy. Cancer Genomics Proteomics 4(3):157-164 (Pubitemid 46813091)
26. Brase JC et al (2010) Increasing the sensitivity of reverse phase protein arrays by antibody-mediated signal amplification. Proteome Sci 8:36
27. Abd El-Rehim DM et al (2005) High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. Int J Cancer 116(3):340-350 (Pubitemid 40993329)
28. Rakha EA et al (2009) Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes. Clin Cancer Res 15(7):2302-2310
29. Aleskandarany MA et al (2010) Growth fraction as a predictor of response to chemotherapy in node-negative breast cancer. Int J Cancer 126(7):1761-1769
30. Sasaki K et al (2009) Significance of twist expression and its association with E-cadherin in esophageal squamous cell carcinoma. J Exp Clin Cancer Res 28:158
31. Bryan RT, Tselepis C (2010) Cadherin switching and bladder cancer. J Urol 184(2):423-431
32. Yilmaz M, Christofori G (2010) Mechanisms of motility in metastasizing cells. Mol Cancer Res 8(5):629-642
33. McCarty KS Jr et al (1985) Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med 109(8):716-721 (Pubitemid 16237466)
34. Nirmalan NJ et al (2009) Development and validation of a novel protein extraction methodology for quantitation of protein expression in formalin-fixed paraffin-embedded tissues using western blotting. J Pathol 217(4):497-506
35. Cheang MC et al (2008) Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res 14(5):1368-1376 (Pubitemid 351413917)
36. Nguyen DX, Massague J (2007) Genetic determinants of cancer metastasis. Nat Rev Genet 8(5):341-352 (Pubitemid 46625811)
37. Yoder BJ, Wilkinson EJ, Massoll NA (2007) Molecular and morphologic distinctions between infiltrating ductal and lobular carcinoma of the breast. Breast J 13(2):172-179 (Pubitemid 46280603)
38. Ellis IO et al (2005) Pathology reporting of breast disease: A joint document incorporating the third edition of the NHS Breast Screening Programme's Guidelines for pathology reporting in breast cancer screening and the second edition of the Royal College of Pathologists' minimum dataset for breast cancer histopathology. In: NHS Cancer Screening Programmes, Royal College of Pathologists, London
39. Marginean F et al (2010) Histological features of medullary carcinoma and prognosis in triple-negative basal-like carcinomas of the breast. Mod Pathol 23(10):1357-1363
40. Aleskandarany M et al (2010) Epithelial mesenchymal transition in invasive breast carcinoma: molecular pathways and relation to molecular subtypes. J Pathol 222(S1):S1-S51
41. Mahler-Araujo B et al (2008) Reduction of E-cadherin expression is associated with non-lobular breast carcinomas of basal-like and triple negative phenotype. J Clin Pathol 61(5):615-620 (Pubitemid 351678214)